Loading...

PGHL Procter & Gamble Health Ltd Changes in management or control Announcement

Prct

PGHL

Procter & Gamble Health Ltd

(PGHL)

2025 Announcement

Q2 Earnings Report

Financial Results

Board Meeting Outcome

Board Meeting Revision

Regulatory Compliance

Management Change

CFO Resignation

Management Change

Management Change

Management Change

IEPF Campaign Support

Promoter Reclassification

Quarterly Results

SEBI Compliance Certificate

Management Change

Analyst Meeting Outcome

Investor Presentation

Management Change

Dividend Declaration

Annual Compliance Report

Investor Meeting

Secretarial Auditors Appointed

Financial Results

Compliance Confirmation

New Directors Appointed

Dividend Announcement

Q2 Financial Results

New Chairperson Appointed

Directorate Change

Director Appointment

Director Appointment

Financial Year Change

Financial Year Change

Compliance Confirmation

Management Change

Q1 Financial Results

Regulatory Compliance

Dividend Announcement

Annual Compliance Report

Q4 2024 Results

Compliance Certificate

Compliance Certificate Subm...

Compliance Certificate

Financial Results Announcement

Certificate Submission

Financial Results

Clarification - Proceedings...

Financial Results for Q3 2023

Certificate Submission

Discontinuation of Production

Dividend income TDS

Compliance Report Submission

Related Party Transaction D...

Financial Statements

Changes in accounting polic...

Changes in Revenue Recognit...

Financial Statements Release

External Links:

Data:

Procter & Gamble Health Ltd has announced the allotment of Director Identification Number (DIN) 11317956 to Mr. Shashank Srowthy, Executive Director, which was issued on September 26, 2025.

AI Assistant

Procter & Gamble Health Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.